{"id":52117,"name":"GENBIOPRO, INC.","slug":"genbiopro-inc","state":"NV","country":"United States of America","description":"Generic Pharmaceutical Manufacturer","totalSpending":500000,"filings":15,"yearlySpending":[{"year":2022,"income":80000},{"year":2023,"income":140000},{"year":2024,"income":140000},{"year":2025,"income":140000}],"issues":["HCR","PHA","FAM","VET"],"firms":["EMERGENT STRATEGIES"],"lobbyists":["SCOTT ECKART","MEGHAN O'HARA"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to medication abortion Issues related to abortion access Issues related to FDA Approval of Mifepristone","Issues related to medication abortion Issues related to abortion access Issues related to FDA Approval of Mifepristone","Issues related to medication abortion Issues related to abortion access Issues related to FDA Approval of Mifepristone","FDA Approval of generic mifepristone and related Risk Evaluation Mitigation Strategies (REMS).","VA rulemaking on providing abortion services to veterans."],"years":[2022,2023,2024,2025]}